Konstantinos Katogiannis
Konstantinos Katogiannis is an expert in Cardiology at University General Hospital Attikon (Greece). Konstantinos Katogiannis has authored 133 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 3 of them ongoing. SLR score: 590 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Gastroenterology - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 133
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Effects of Nutritional Supplements on Vascular Function: A Narrative Review. PMID 42513607 — arginine, glycocalyx, mitochondria, oxidative stress, citrulline, polyphenols | J Clin Med | 2026 | 0 |
| Coronary Flow Reserve in Adults: Pathophysiology, Assessment Modalities, Clinical Applications, and Prognostic Significance. PMID 42356048 — microcirculation, arteries, echocardiography, prognosis, cardiomyopathies | Medicina (Kaunas) | 2026 | 2 |
| Effects of dapagliflozin and dulaglutide on blood pressure and coronary flow in liver steatosis patients with type 2 diabetes. PMID 42201656 — diabetes mellitus, hypertension, blood, glycocalyx, blood pressure, liver, therapeutics, diabetes mellitus, type 2 | J Hypertens | 2026 | 0 |
| Air Travel in Patients with Acute Coronary Syndromes or Heart Failure: Current Evidence, Guidance and Gaps. PMID 42170902 — registries, travel, heart failure, heart, cardiovascular diseases, acute coronary syndrome, air, clinical medicine, air travel | Eur Heart J Qual Care Clin Outcomes | 2026 | 1 |
| Vascular and Myocardial Function in Patients with Type 2 Diabetes and Ischemic Stroke Treated with Dulaglutide or Empagliflozin. PMID 41752654 — diabetes mellitus, ischemic stroke, stroke, glycocalyx, therapeutics, diabetes mellitus, type 2, myocardial strain | Medicina (Kaunas) | 2026 | 0 |
Clinical Studies 15
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| The Effect of Coenzyme Q10 on Endothelial Vascular and Myocardial Function NCT05941910 — liver diseases, coenzymes, glycocalyx, non-alcoholic fatty liver disease, liver, alcoholics, therapeutics, fatty liver, fatty liver, alcoholic | Phase 2 | Recruiting | 2023 |
| The Effect of Dietary Intervation on Endothelial Glycocalyx in COVID 19 Patients NCT05185934 — microcirculation, glycocalyx, dietary supplements, food, covid-19, infections | N/A | Recruiting | 2022 |
| The Effect of Dietary Intervention on Endothelial Glycocalyx in Psoriasis NCT05184699 — microcirculation, glycocalyx, dietary supplements, food, psoriasis | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map